U.S. flag

An official website of the United States government

NM_014225.6(PPP2R1A):c.544C>T (p.Arg182Trp) AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Dec 12, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000412854.12

Allele description [Variation Report for NM_014225.6(PPP2R1A):c.544C>T (p.Arg182Trp)]

NM_014225.6(PPP2R1A):c.544C>T (p.Arg182Trp)

Gene:
PPP2R1A:protein phosphatase 2 scaffold subunit Aalpha [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.41
Genomic location:
Preferred name:
NM_014225.6(PPP2R1A):c.544C>T (p.Arg182Trp)
HGVS:
  • NC_000019.10:g.52212726C>T
  • NG_047068.1:g.27925C>T
  • NM_001363656.2:c.7C>T
  • NM_014225.6:c.544C>TMANE SELECT
  • NP_001350585.1:p.Arg3Trp
  • NP_055040.2:p.Arg182Trp
  • NC_000019.9:g.52715979C>T
  • NM_014225.5:c.544C>T
  • NR_033500.2:n.488C>T
  • P30153:p.Arg182Trp
Protein change:
R182W; ARG182TRP
Links:
UniProtKB: P30153#VAR_074489; OMIM: 605983.0001; dbSNP: rs786205227
NCBI 1000 Genomes Browser:
rs786205227
Molecular consequence:
  • NM_001363656.2:c.7C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_014225.6:c.544C>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_033500.2:n.488C>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000491305GeneDx
criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)
Pathogenic
(Sep 29, 2021)
germlineclinical testing

Citation Link,

SCV001585609Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 12, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Large-scale discovery of novel genetic causes of developmental disorders.

Deciphering Developmental Disorders Study..

Nature. 2015 Mar 12;519(7542):223-8. doi: 10.1038/nature14135. Epub 2014 Dec 24.

PubMed [citation]
PMID:
25533962
PMCID:
PMC5955210

B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability.

Houge G, Haesen D, Vissers LE, Mehta S, Parker MJ, Wright M, Vogt J, McKee S, Tolmie JL, Cordeiro N, Kleefstra T, Willemsen MH, Reijnders MR, Berland S, Hayman E, Lahat E, Brilstra EH, van Gassen KL, Zonneveld-Huijssoon E, de Bie CI, Hoischen A, Eichler EE, et al.

J Clin Invest. 2015 Aug 3;125(8):3051-62. doi: 10.1172/JCI79860. Epub 2015 Jul 13.

PubMed [citation]
PMID:
26168268
PMCID:
PMC4623570
See all PubMed Citations (3)

Details of each submission

From GeneDx, SCV000491305.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Published functional studies demonstrate that R182W affects PP2A holoenzyme formation, and PR72 binding is prevented due to the presence of the R182W mutant protein. Additionally, PP2A phosphatase activity is decreased for the R182W mutant compared to the wild type (Houge et al., 2015).; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 25533962, 26168268, 28628100, 28867141, 28135719, 32565546)

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001585609.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 182 of the PPP2R1A protein (p.Arg182Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with intellectual disability and developmental delay (PMID: 25533962, 26168268). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 190312). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PPP2R1A protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects PPP2R1A function (PMID: 26168268). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024